340 related articles for article (PubMed ID: 3276038)
21. A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses.
Priestley CA; Dalchau R; Sawyer GJ; Fabre JW
Transplantation; 1989 Dec; 48(6):1031-8. PubMed ID: 2595764
[TBL] [Abstract][Full Text] [Related]
22. Persistent infiltration of CD45RC- CD4+ T cells, Th2-like effector cells, in prolonging hepatic allografts in rats pretreated with a donor-specific blood transfusion.
Miyanari N; Yamaguchi Y; Matsuno K; Tominaga A; Goto M; Ichiguchi O; Mori K; Ogawa M
Hepatology; 1997 Apr; 25(4):1008-13. PubMed ID: 9096612
[TBL] [Abstract][Full Text] [Related]
23. Role of platelet activating factor in kidney transplant rejection in the rat.
Butterly DW; Spurney RF; Ruiz P; Pirotzky E; Braquet P; Coffman TM
Kidney Int; 1995 Aug; 48(2):337-43. PubMed ID: 7564100
[TBL] [Abstract][Full Text] [Related]
24. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat.
Lowry RP; Forbes RD; Blackburn JH; Marghesco DM
Transplantation; 1985 Nov; 40(5):545-50. PubMed ID: 3904091
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis and the expression of genes of the Bcl-2 family and TGF-beta1 in rat renal allografts transplanted after donor-specific blood transfusion.
Jablonski P; Goh BL; Maguire J; Glogowski I; Howden BO; Thomson NM; Stein AN
Transplant Proc; 2005; 37(1):93-5. PubMed ID: 15808558
[TBL] [Abstract][Full Text] [Related]
26. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity.
Gracie JA; Bolton EM; Porteous C; Bradley JA
J Exp Med; 1990 Dec; 172(6):1547-57. PubMed ID: 2258695
[TBL] [Abstract][Full Text] [Related]
27. Immunobiology and long-term graft function in a transplant heterotopic renal rat model.
Maluf DG; Fisher RA; Riley R; Wallace M; Tawes J; Bu D; Posner M
Clin Transplant; 2002; 16 Suppl 7():6-14. PubMed ID: 12372038
[TBL] [Abstract][Full Text] [Related]
28. Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptance.
Knechtle SJ; Wolfe JA; Burchette J; Sanfilippo F; Bollinger RR
Transplantation; 1987 Feb; 43(2):169-72. PubMed ID: 3544371
[TBL] [Abstract][Full Text] [Related]
29. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
Yu S; Nakafusa Y; Flye MW
Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
[TBL] [Abstract][Full Text] [Related]
30. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
[TBL] [Abstract][Full Text] [Related]
31. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
Yang CP; Shittu E; Bell EB
J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
[TBL] [Abstract][Full Text] [Related]
32. Functional role of thromboxane production by acutely rejecting renal allografts in rats.
Coffman TM; Yarger WE; Klotman PE
J Clin Invest; 1985 Apr; 75(4):1242-8. PubMed ID: 3886703
[TBL] [Abstract][Full Text] [Related]
33. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts.
Coffman TM; Ruiz P; Sanfilippo F; Klotman PE
Kidney Int; 1989 Jan; 35(1):24-30. PubMed ID: 2651752
[TBL] [Abstract][Full Text] [Related]
34. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
Lowry RP; Gurley KE
Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
[TBL] [Abstract][Full Text] [Related]
35. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model.
Hanaway MJ; Geissler EK; Wang J; Fechner JH; Buelow R; Knechtle SJ
Transplantation; 1996 Apr; 61(8):1222-8. PubMed ID: 8610422
[TBL] [Abstract][Full Text] [Related]
37. Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone.
Mannon RB; Sundar SK; Sanfilippo FP; Coffman TM
Transplantation; 1993 Nov; 56(5):1157-62. PubMed ID: 8249118
[TBL] [Abstract][Full Text] [Related]
38. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
[TBL] [Abstract][Full Text] [Related]
39. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
[TBL] [Abstract][Full Text] [Related]
40. Break of tolerance via donor-specific blood transfusion by high doses of steroids: a differential effect after intestinal transplantation and heart transplantation.
Koshiba T; Kitade H; Waer M; Mathieu C; Van Damme B; Pirenne J
Transplant Proc; 2003 Dec; 35(8):3153-5. PubMed ID: 14698001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
